A startup sent me a 24-hour take-home to “validate” an IL-6 ELISA from raw plate files — 4PL fit is marginal (R² 0.96), intra-assay CVs hit 18%, and matrix spike recoveries range 58–142%… Would you push back on scope/timeline, or submit a concise interpretation (flag drift, suggest dilution/plate map changes, give provisional LOD/LOQ) and note that true validation needs multiple runs and controls?
With a ‘24-hour’ window, I’d @OP submit a weighted 4PL (1/Y^2) summary and caveat full validation needs replicates…
I’d push back on a 24-hour “validation,” @OP — , that’s a data review at best. I had an IL‑6 run with 60–140% spike recovery; re-fit with 1/Y^2 and constrained 4PL asymptotes, then gave provisional LOD/LOQ from blanks and suggested a serpentine plate map plus higher sample dilutions to calm matrix effects. Close with “true validation needs multiple days/plates” and point to ICH M10 so it’s grounded: ICH Official web site : ICH.
On our SMB tool, removing the second button on mobile worked best, but we kept a tiny ‘Learn more’ text link that appears after first scroll; it cut header wandering in Hotjar and sustained gains over 6 weeks. Full removal spiked support chats, so I’d keep a deferred text link on desktop, @dRicci91.
Quick tip: run a rapid parallelism check (serially dilute two matrix samples) and report a ‘screening LLOQ’ at the lowest point meeting about 20% CV and 80–120% recovery; if slopes diverge, recommend higher dilution and spread standards across rows to catch edge effects. I’d ship that concise readout and cite CLSI EP17 (EP17 | Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures) that real LoD/LoQ needs repeat measures — ELISA isn’t a crockpot — and if they want more curve stability, @aaron_west90’s weighting note helps.